ADAR1 Capital Management, LLC

Registered adviser

CIK

1940272

Location

AUSTIN, TX

Portfolio Value

Mid $2,164,684,267

Diversification

Diversified

Filing Date

Global Rank

#1,518 / 8,818 ▲ 108

Top Industry

Biotechnology 89.9%

Period ended 4 months ago

Filed Aug 14, 2026 · 2mo

11 quarters · since Dec 2023

Regulatory profile

From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.

Holder type

Registered adviser

Form ADV roster, Oct 1, 2026

Form ADV adviser

CRD 299694

Roster of Oct 1, 2026

Regulatory AUM

$1,675,126,109

Main clients

Pooled investment vehicles (100% of AUM)

Private funds

2 funds · Hedge funds

Focus by fund count, roster of Oct 1, 2026

$1,292,617,858 gross assets

LEI

549300YNEBMYE1SWQH64

Private funds on Schedule D 7.B.(1)

As filed Mar 28, 2024; SEC's bulk Form ADV archive ends with 2024 filings.

$484,122,240 gross assets in 1 fund Hedge funds $484,122,240 (1)

Form ADV history

Monthly rosters from Dec 2019; each row is a run with the same figures, newest first.

Rosters	Regulatory AUM	Main clients
Apr 2026 to Oct 2026	$1,675,126,109	Pooled investment vehicles (100%)
Apr 2025 to Mar 2026	$819,928,476	Pooled investment vehicles (100%)
May 2024 to Mar 2025	$507,774,765	Pooled investment vehicles (100%)

Portfolio style

Measured from the filed 13F common-share book for Jun 30, 2026, never from the firm's own description.

Style

Diversified active

Top 10 weight 42.3%, 34.3 effective positions, active share 94.3% against the Russell 2000 as of 2026-06-30; it meets none of the index-like, systematic-like or concentrated tests

Turnover

Medium turnover

58.5% over the last four quarters (30% to under 100%)

Horizon

Medium horizon

Value-weighted holding period 7.3 quarters (4 to under 12)

Closest benchmark: the Russell 2000 as of 2026-06-30, active share 94.3%; sector active share 81.1% against the combined 13F book's sector weights.

Over time 11 measured quarters

How the bands are measured

Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.

Clone Performance

Build a hypothetical price-return history from this filer's public 13F holdings.

View clone backtest

Portfolio Concentration

266 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026

Top Position

11.4%

+1.9 pts

Top 5

31.4%

+2.9 pts

Top 10

42.4%

+1.5 pts

HHI

292

Diversified+34

Portfolio Trend

11 quarters · across all stocks

Sector Breakdown

As of Jun 30, 2026

Sector	% Portfolio	Value	Positions
Healthcare	88.2%	$1,909,777,688	233
Unclassified	9.1%	$197,564,947	8
Financial Services	2.5%	$53,636,214	17
Real Estate	0.0%	$1,030,575	1
Communication Services	0.0%	$1,012,077	1
Industrials	0.0%	$777,150	2
Consumer Cyclical	0.0%	$598,216	2
Technology	0.0%	$195,000	1
Consumer Defensive	0.0%	$92,400	1

Last Quarter's Activity

Export CSV

Jun 30, 2026 vs Mar 31, 2026

Added To

Positions the filer increased

25 positions

Ticker	Company	Δ Shares	Shares	Value
PLRX	Pliant Therapeutics, Inc.	+2,924,598	5,509,724	$6,281,085
OVID	Ovid Therapeutics Inc.	+2,873,366	7,417,479	$19,953,018
IFRX	InflaRx N.V.	+2,841,729	3,000,000	$6,720,000
ENGN	enGene Therapeutics Inc.	+1,971,300	2,104,986	$3,641,625
ZLAB	Zai Lab Ltd	+1,943,667	3,369,034	$64,011,646
YARW	Yarrow Bioscience, Inc.	+1,886,101	2,950,000	$1,920,450
ALEC	Alector, Inc.	+1,833,583	2,883,583	$5,796,001
FULC	Fulcrum Therapeutics, Inc.	+1,434,469	1,565,029	$5,728,006
IVA	Inventiva S.A.	+1,432,258	3,606,656	$13,633,159
ENTA	Enanta Pharmaceuticals Inc	+1,293,153	1,344,510	$19,602,955
WHWK	Whitehawk Therapeutics, Inc.	+1,212,891	1,341,394	$6,143,584
AGIO	Agios Pharmaceuticals, Inc.	+1,147,381	1,288,053	$47,799,646
ZURA	Zura Bio Ltd	+1,128,892	1,759,295	$10,379,840
PEPG	PepGen Inc.	+983,447	2,591,085	$4,663,953
RLYB	Rallybio Corp	+905,817	926,352	$14,821,632
ANL	Adlai Nortye Group Ltd.	+899,896	1,017,805	$11,704,757
IKT	Inhibikase Therapeutics, Inc.	+780,633	7,387,205	$14,996,026
PRLD	Prelude Therapeutics Inc	+748,075	900,900	$4,801,797
INO	Inovio Pharmaceuticals, Inc.	+673,802	2,143,910	$2,358,301
ZNTL	Zentalis Pharmaceuticals, Inc.	+508,114	652,750	$3,165,837
SRPT	Sarepta Therapeutics, Inc.	+468,591	730,649	$13,129,762
CATX	Perspective Therapeutics, Inc.	+460,782	1,210,117	$4,126,498
BHVN	Biohaven Ltd.	+456,910	501,687	$7,465,102
TRAW	Traws Pharma, Inc.	+443,631	597,729	$502,092
ABVX	Abivax S.A.	+410,684	1,804,703	$240,494,721
No positions match the current search.

Trimmed

Positions the filer reduced

25 positions

Ticker	Company	Δ Shares	Shares	Value
ABUS	Arbutus Biopharma Corp	−1,865,028	1,268,147	$6,087,105
REPL	Replimune Group, Inc.	−927,203	655,784	$7,259,528
DNLI	Denali Therapeutics Inc.	−842,375	1,029,080	$26,467,937
SPRY	ARS Pharmaceuticals, Inc.	−760,537	600,999	$4,814,001
AVR	Anteris Technologies Global Corp.	−644,036	3,145,096	$30,979,195
PALI	Palisade Bio, Inc.	−538,183	1,726,662	$3,608,723
AMLX	Amylyx Pharmaceuticals, Inc.	−506,226	494,378	$8,879,028
DBVT	DBV Technologies S.A.	−484,571	528,295	$8,664,038
MLTX	MoonLake Immunotherapeutics	−430,137	27,000	$525,690
VTGN	Vistagen Therapeutics, Inc.	−400,000	351,141	$80,762
MPLT	MapLight Therapeutics, Inc.	−348,412	26,497	$949,652
IMVT	Immunovant, Inc.	−348,294	2,330,716	$89,802,487
ELDN	Eledon Pharmaceuticals, Inc.	−326,609	647,812	$2,552,379
VIR	Vir Biotechnology, Inc.	−288,037	2,456,677	$25,033,538
SNY	Sanofi	−259,839	57,100	$2,435,886
OKUR	OnKure Therapeutics, Inc.	−196,257	2,238,684	$10,208,399
CYTK	Cytokinetics Inc	−174,649	457,907	$39,009,097
AEXA	American Exceptionalism Acquisition Corp. A	−152,131	205,408	$2,427,922
SEPN	Septerna, Inc.	−149,071	940,747	$31,505,617
URGN	UroGen Pharma Ltd.	−143,064	252,395	$9,288,136
ROIV	Roivant Sciences Ltd.	−128,898	3,157,008	$111,726,513
STRO	Sutro Biopharma, Inc.	−120,427	404,014	$13,413,264
PCVX	Vaxcyte, Inc.	−113,103	146,034	$8,488,956
IBIO	iBio, Inc.	−94,347	375,531	$657,179
LGVN	Longeveron Inc.	−91,594	108,406	$76,209
No positions match the current search.

New Positions

Positions the filer opened this quarter

25 positions

Ticker	Company	Shares	Value
EDIT	Editas Medicine, Inc.	8,889,000	$28,800,360
VOR	Vor Biopharma Inc.	680,626	$12,530,324
FTH	Faeth Therapeutics, Inc.	361,010	$9,025,250
AMAN	Amanat Acquisition Corp.	750,000	$7,620,000
RACC	Research Alliance Corp III	650,000	$6,955,000
RLAY	Relay Therapeutics, Inc.	358,333	$6,704,410
BOLD	Boundless Bio, Inc.	1,968,216	$4,920,540
AVLN	Avalyn Pharma Inc.	146,447	$4,821,035
JATT	JATT II Acquisition Corp.	417,724	$4,745,344
RNTX	Rein Therapeutics, Inc.	4,500,000	$4,680,000
—		31,000	$4,114,630
SGMT	Sagimet Biosciences Inc.	437,500	$3,381,875
CUE	Cue Biopharma, Inc.	55,193	$1,741,891
TRAX	First Tracks Biotherapeutics, Inc.	71,910	$1,446,829
INM	InMed Pharmaceuticals Inc.	800,000	$1,240,000
ARTV	Artiva Biotherapeutics, Inc.	118,624	$1,150,652
ALXO	Alx Oncology Holdings Inc	533,660	$1,104,676
RNAC	Cartesian Therapeutics, Inc.	98,877	$1,030,298
KRSA	Korsana Biosciences, Inc.	298,757	$1,012,786
ACAD	Acadia Pharmaceuticals Inc	38,955	$985,561
GPCR	Structure Therapeutics Inc.	17,500	$939,225
AURA	Aura Biosciences, Inc.	130,152	$924,079
CCXI	Churchill Capital Corp XI	50,000	$872,500
KZIA	Kazia Therapeutics Ltd	61,550	$866,624
SYK	Stryker Corp	2,000	$629,680
No positions match the current search.

Sold Out

Positions the filer fully exited

25 positions

Ticker	Company	Shares	Value
—		914,699	$48,222,931
BEAM	Beam Therapeutics Inc.	1,446,375	$34,467,116
SRRK	Scholar Rock Holding Corp	407,273	$20,021,540
VRTX	Vertex Pharmaceuticals Inc	15,075	$6,731,590
VRDN	Viridian Therapeutics, Inc.\DE	304,422	$5,954,494
LLY	ELI LILLY & Co	5,060	$4,654,036
DNTH	Dianthus Therapeutics, Inc.	55,000	$4,615,600
BLTE	Belite Bio, Inc	26,880	$4,285,747
—		32,084	$3,683,885
AVBP	ArriVent BioPharma, Inc.	141,814	$3,271,648
—		72,500	$2,916,675
—		15,000	$2,668,050
TFX	Teleflex Inc	21,186	$2,534,057
BIOA	BioAge Labs, Inc.	135,560	$2,370,944
ALKS	Alkermes plc.	46,400	$1,640,704
—		46,830	$1,567,868
CNTA	Centessa Pharmaceuticals plc	38,566	$1,531,842
—		105,000	$1,518,300
UNH	Unitedhealth Group Inc	5,501	$1,488,515
SXT	Sensient Technologies Corp	15,000	$1,296,600
SDGR	Schrodinger, Inc.	101,500	$1,153,040
FDMT	4D Molecular Therapeutics, Inc.	116,712	$1,086,588
—		49,923	$1,070,349
BMY	Bristol Myers Squibb Co	17,500	$1,061,375
BSAAU	BEST SPAC I Acquisition Corp.	100,000	$1,040,000
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

266 tracked positions · $2,164,684,267 total · filing declares 277 positions · $2,185,183,006 · as of Jun 30, 2026

All sectors Communication Services Consumer Cyclical Consumer Defensive Financial Services Healthcare Industrials Real Estate Technology

Showing 1–50 of 266 positions by value · page 1 of 6

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	Held (qtrs)	Est. cost/share	% of Portfolio
ABVX	Abivax S.A. CALL + SHARES Healthcare	Added	1,849,103	+411,084	$246,411,465	+53.9%	10	$36.90	11.38%
PTGX	Protagonist Therapeutics, Inc Healthcare	Reduced	960,863	-33,256	$117,782,586	+12.4%	11	before history	5.44%
SPY	Spdr S&P 500 ETF Trust PUT + SHARES	Added	154,087	+78,147	$115,067,548	+133.0%	5	$669.81	5.32%
ROIV	Roivant Sciences Ltd. Healthcare	Reduced	3,157,008	-128,898	$111,726,513	+22.7%	11	before history	5.16%
IMVT	Immunovant, Inc. Healthcare	Reduced	2,330,716	-348,294	$89,802,487	+34.9%	11	before history	4.15%
ZLAB	Zai Lab Ltd Healthcare	Added	3,369,034	+1,943,667	$64,011,646	+138.8%	11	before history	2.96%
AGIO	Agios Pharmaceuticals, Inc. Healthcare	Added	1,288,053	+1,147,381	$47,799,646	+904.4%	6	$30.80	2.21%
		Added	1,222,080	+82,749	$45,730,233	+10.5%	9	$42.23	2.11%
BOXX	Alpha Architect 1-3 Month Box ETF	Held	337,125	0	$39,473,966	+0.7%	10	unpriced	1.82%
CYTK	Cytokinetics Inc Healthcare	Reduced	457,907	-174,649	$39,009,097	−6.4%	11	before history	1.80%
SEPN	Septerna, Inc. Healthcare	Reduced	940,747	-149,071	$31,505,617	+20.3%	6	$11.55	1.46%
AVR	Anteris Technologies Global Corp. Healthcare	Reduced	3,145,096	-644,036	$30,979,195	+47.3%	7	unpriced	1.43%
EDIT	Editas Medicine, Inc. Healthcare	NEW	8,889,000	NEW	$28,800,360	NEW	1	$2.92	1.33%
DNLI	Denali Therapeutics Inc. Healthcare	Reduced	1,029,080	-842,375	$26,467,937	−26.3%	10	$19.80	1.22%
SYRE	Spyre Therapeutics, Inc. Healthcare	Reduced	283,982	-54,341	$25,211,921	+47.7%	6	$35.66	1.16%
VIR	Vir Biotechnology, Inc. Healthcare	Reduced	2,456,677	-288,037	$25,033,538	+1.8%	2	$7.97	1.16%
PRAX	Praxis Precision Medicines, Inc. Healthcare	Added	74,253	+72,753	$24,859,161	+5043.8%	3	$313.93	1.15%
INSM	INSMED Inc Healthcare	Added	228,520	+193,128	$24,364,802	+321.0%	2	$126.15	1.13%
CLDX	Celldex Therapeutics, Inc. Healthcare	Added	619,542	+191,726	$23,053,157	+69.9%	6	$27.63	1.06%
VKTX	Viking Therapeutics, Inc. Healthcare	Added	574,038	+346,321	$22,393,222	+202.2%	11	before history	1.03%
TSHA	Taysha Gene Therapies, Inc. Healthcare	Added	3,040,466	+61,037	$20,705,573	+55.5%	11	before history	0.96%
MNPR	Monopar Therapeutics Healthcare	Reduced	217,595	-46,683	$20,147,121	+39.1%	7	$50.40	0.93%
OVID	Ovid Therapeutics Inc. Healthcare	Added	7,417,479	+2,873,366	$19,953,018	+97.8%	11	before history	0.92%
ELVN	Enliven Therapeutics, Inc. Healthcare	Added	387,718	+58,178	$19,676,688	+52.3%	3	$29.32	0.91%
ENTA	Enanta Pharmaceuticals Inc Healthcare	Added	1,344,510	+1,293,153	$19,602,955	+2922.2%	3	$13.42	0.91%
IWM	iShares Russell 2000 ETF PUT	Added	62,500	+35,000	$18,778,125	+175.3%	—	—	0.87%
NKTR	Nektar Therapeutics Healthcare	Added	244,184	+82,932	$17,046,485	+46.9%	8	unpriced	0.79%
INSP	Inspire Medical Systems, Inc. Healthcare	Reduced	374,617	-30,580	$16,711,664	−20.0%	4	$71.04	0.77%
RVMD	Revolution Medicines, Inc. Healthcare	Reduced	87,509	-46,384	$16,388,685	+25.9%	8	$48.72	0.76%
ESTA	Establishment Labs Holdings Inc. Healthcare	Reduced	185,619	-27,854	$15,927,966	+31.4%	6	$53.03	0.74%
PRTA	Prothena Corp Public Ltd Co Healthcare	Reduced	1,554,535	-26,908	$15,218,897	−1.0%	5	$7.63	0.70%
RYTM	Rhythm Pharmaceuticals, Inc. Healthcare	Reduced	136,158	-75,292	$15,117,622	−17.8%	7	$88.47	0.70%
IKT	Inhibikase Therapeutics, Inc. Healthcare	Added	7,387,205	+780,633	$14,996,026	+35.1%	7	$2.13	0.69%
QURE	uniQure N.V. Healthcare	Added	324,672	+148,466	$14,954,392	+419.1%	4	$26.37	0.69%
RLYB	Rallybio Corp Healthcare	Added	926,352	+905,817	$14,821,632	+7946.6%	2	unpriced	0.68%
REGN	Regeneron Pharmaceuticals, Inc. Healthcare	Added	22,208	+10,054	$13,847,576	+47.5%	8	$639.14	0.64%
IVA	Inventiva S.A. Healthcare	Added	3,606,656	+1,432,258	$13,633,159	+13.0%	3	$4.71	0.63%
STRO	Sutro Biopharma, Inc. Healthcare	Reduced	404,014	-120,427	$13,413,264	+2.7%	3	unpriced	0.62%
IONS	Ionis Pharmaceuticals Inc Healthcare	Added	166,286	+5,948	$13,184,816	+9.5%	5	$41.32	0.61%
BBIO	BridgeBio Pharma, Inc. Healthcare	Added	176,689	+82,397	$13,159,796	+87.9%	11	before history	0.61%
SRPT	Sarepta Therapeutics, Inc. Healthcare	Added	730,649	+468,591	$13,129,762	+130.3%	11	before history	0.61%
CTMX	CytomX Therapeutics, Inc. Healthcare	Reduced	3,365,118	-45,072	$12,619,192	−21.3%	10	$1.83	0.58%
VOR	Vor Biopharma Inc. Healthcare	NEW	680,626	NEW	$12,530,324	NEW	1	$15.13	0.58%
		Held	135,585	0	$12,425,009	0.0%	11	before history	0.57%
EQ	Equillium, Inc. Healthcare	Added	3,758,569	+31,910	$12,027,420	+61.4%	4	$1.07	0.56%
ANL	Adlai Nortye Group Ltd. Healthcare	Added	1,017,805	+899,896	$11,704,757	+1334.5%	2	$11.53	0.54%
CLYM	Climb Bio, Inc. Healthcare	Added	822,649	+224,987	$10,727,342	+162.0%	9	$4.64	0.50%
XBI	State Street(R) SPDR(R) S&P(R) Biotech ETF PUT	Added	67,400	+52,400	$10,666,050	+456.7%	—	—	0.49%
HLXC	Helix Acquisition Corp. III Financial Services	Held	1,000,000	0	$10,640,000	+4.7%	2	$10.24	0.49%
ZURA	Zura Bio Ltd Healthcare	Added	1,759,295	+1,128,892	$10,379,840	+176.7%	8	$4.31	0.48%

Showing the top 50 of 266 positions. Create a free account to see every position, past quarters, search, filters and CSV export.

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.